Contact us
Products overview

March 23, 2022

Blog

LogiMed 2022: Three Takeaways for Medical Device Companies

by Laura Johnson

LogiMed 2022, which took place earlier this month in San Diego, CA, brought together the entire healthcare supply chain for two days of insightful keynotes, case studies, panel discussions, and roundtables.  

Attendees learned about best practices to improve their end-to-end supply chain, better serve customers, and minimize costs as the world navigates through and beyond the COVID-19 pandemic.  

Read on for three topics discussed at the conference.  

#1 COVID-19 will have a lasting impact. While many thought the COVID-19 situation would be resolved by now, several industries are still having to adapt operations to cope with changes. Panelists at LogiMed discussed ways the medical device industry can proactively soften the blow of future disruptions. Our view is that adopting a modern labeling solution can help companies navigate these changes and future-proof their operations for the long haul. For example, when medical device manufacturers adopt labeling ecosystems that extend across their end-to-end operations, they can readily address any regulatory nuances, maintain strict controls, and ensure continuous operations. 

#2 Supply chain agility is top of mind. An inefficient supply chain equals slower time-to-market, decreased competitive advantage, and the inability to scale across the enterprise. So, how do medical device companies manage this? According to our recent blog, the implementation of a modern Enterprise Labeling solution provides transparency, traceability, cost savings, improved quality, and the ability to scale.  

#3 Digitalization will be a key trend in 2022 and beyond. While some in the industry look at digitalization as a new buzzword, others are fearful that hospitals are digitizing their supply chains faster than suppliers can keep up. As we noted in our ‘Top 5 Trends in Labeling & Packaging Artwork' report, digital transformation allows more flexibility to scale and to adapt to change. It is a vital tool for medical device companies who need to respond to new risks, shift their business models, and leverage new opportunities using current resources.  

To learn more about these key takeaways, download our report, 'Turning Roadblocks into Pathways to Success'